Gelmap. Spot visualization by LUH

Peptidelist

ID1FDRAccessionNameRankPep_isboldPep_isuniquePep_exp_mzPep_exp_mrPep_exp_zPep_calc_mrPep_deltaPep_missPep_scorePep_seqPep_var_modPep_var_mod_posTypePep_scan_title
79<0.01ATCG00680.1PsbB, CP47111549.3191548.31181548.30710.0047017.41GGLFRCID Cmpd 54, +MSn(549.3191), 13.5 min
79<0.01ATCG00680.1PsbB, CP47111410.2468818.47902818.47630.0028124.54ELFVRRCID Cmpd 27, +MSn(410.2468), 12.3 min
79<0.01ATCG00680.1PsbB, CP47111444.2517886.48892886.48720.0017130.71LGDPTTKRCID Cmpd 1, +MSn(444.2517), 8.0 min
79<0.01ATCG00680.1PsbB, CP47111528.30961054.604621054.60220.0024048.16TGKPSLDLPKCID Cmpd 55, +MSn(528.3096), 13.5 min
79<0.01ATCG00680.1PsbB, CP47111547.30551092.596521092.59280.0037152.64ATLKSDGVFRCID Cmpd 47, +MSn(547.3055), 13.0 min
79<0.01ATCG00680.1PsbB, CP47111603.83811205.661721205.65170.0100051.31VHTVVLNDPGRCID Cmpd 30, +MSn(603.8381), 12.4 min
79<0.01ATCG00680.1PsbB, CP47111645.84471289.674921289.66150.0134058.50AQLGEIFELDRCID Cmpd 188, +MSn(645.8447), 21.0 min
79<0.01ATCG00680.1PsbB, CP47111671.84301341.671421341.65740.0141062.08QGMFVIPFMTROxidation (M)0.00200000000.0CID Cmpd 197, +MSn(671.8430), 22.4 min
79<0.01ATCG00680.1PsbB, CP47111743.38321484.751821484.72990.0219063.39LAFYDYIGNNPAKCID Cmpd 179, +MSn(743.3832), 19.9 min
79<0.01ATCG00680.1PsbB, CP47111482.93361445.779131445.76260.0164160.14RAQLGEIFELDRCID Cmpd 173, +MSn(482.9336), 19.4 min
79<0.01ATCG00680.1PsbB, CP47111651.68441952.031531952.00430.0272122.94IPEKLAFYDYIGNNPAKCID Cmpd 175, +MSn(651.6844), 19.4 min
79<0.01ATCG00680.1PsbB, CP47110663.3881662.38081662.37520.0057030.92ELFVRCID Cmpd 94, +MSn(663.3881), 14.8 min
79<0.01ATCG00680.1PsbB, CP47511430.7423859.46992859.46640.0035123.29ADVPFRRCID Cmpd 17, +MSn(430.7422), 11.6 min
79<0.01ATCG00280.1PsbC, CP43111464.7495927.48442927.47740.0070049.62GPNGLDLSRCID Cmpd 60, +MSn(464.7495), 13.7 min
79<0.01ATCG00280.1PsbC, CP43111536.26971070.524921070.51450.0104042.51DIQPWQERCID Cmpd 109, +MSn(536.2697), 15.3 min
79<0.01ATCG00280.1PsbC, CP43111713.89561425.776721425.75760.01910106.79LGANVGSAQGPTGLGKCID Cmpd 65, +MSn(713.8956), 13.9 min
79<0.01ATCG00280.1PsbC, CP43111740.87171479.728821479.70280.0260045.98SPTGEVIFGGETMRCID Cmpd 158, +MSn(740.8717), 18.1 min
79<0.01AT2G28000.1Cpn60A, CH-CPN60A, SLP, chaperonin-60 alpha 111531.78711061.559721061.55050.0092048.02LLAEFENARCID Cmpd 128, +MSn(531.7871), 16.6 min
79<0.01AT2G28000.1Cpn60A, CH-CPN60A, SLP, chaperonin-60 alpha 111645.82111289.627521289.60990.0176066.40VGAATETELEDRCID Cmpd 43, +MSn(645.8210), 12.9 min
79<0.01AT5G35630.1GS2, GLN2, ATGSL1, glutamine synthetase 2 (Gene mo111450.2900898.56552898.56000.0055025.23AILNLSLRCID Cmpd 171, +MSn(450.2900), 19.3 min
79<0.01AT5G35630.1GS2, GLN2, ATGSL1, glutamine synthetase 2 (Gene mo111527.95641580.847431580.82970.0177051.34TIEKPVEDPSELPKCID Cmpd 66, +MSn(527.9564), 13.9 min
79<0.01AT5G35630.2GS2, GLN2, ATGSL1, glutamine synthetase 2 (Gene mo101450.2900898.56552898.56000.0055025.23AILNLSLRCID Cmpd 171, +MSn(450.2900), 19.3 min
79<0.01AT5G35630.2GS2, GLN2, ATGSL1, glutamine synthetase 2 (Gene mo101527.95641580.847431580.82970.0177051.34TIEKPVEDPSELPKCID Cmpd 66, +MSn(527.9564), 13.9 min
79<0.01AT5G35630.3GS2, GLN2, ATGSL1, glutamine synthetase 2 (Gene mo101450.2900898.56552898.56000.0055025.23AILNLSLRCID Cmpd 171, +MSn(450.2900), 19.3 min
79<0.01AT5G35630.3GS2, GLN2, ATGSL1, glutamine synthetase 2 (Gene mo101527.95641580.847431580.82970.0177051.34TIEKPVEDPSELPKCID Cmpd 66, +MSn(527.9564), 13.9 min
79<0.01AT2G39730.1RCA, rubisco activase (Gene model 1)111504.27761006.540621006.53350.0071045.49FVESLGVEKCID Cmpd 105, +MSn(504.2776), 15.2 min
79<0.01AT2G39730.2RCA, rubisco activase (Gene model 2)101504.27761006.540621006.53350.0071045.49FVESLGVEKCID Cmpd 105, +MSn(504.2776), 15.2 min
79<0.01AT2G39730.3RCA, rubisco activase (Gene model 3)101504.27761006.540621006.53350.0071045.49FVESLGVEKCID Cmpd 105, +MSn(504.2776), 15.2 min
79<0.05AT2G01210.1Leucine-rich repeat protein kinase family protein111435.7759869.53722869.53340.0038026.62VVSLSIPRCID Cmpd 95, +MSn(435.7759), 14.9 min